Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > New Press Release - Theralase(R) Provides Update on Bladder Cancer Clinical Study
View:
Comment by Lesalpes29 on Oct 16, 2023 7:08am
Good to see an uptdate. Still very positive. GL
Comment by Lesalpes29 on Oct 16, 2023 7:27am
Theralase® is currently working with its clinical study sites in Canada and the United States to compile information requested by the Food and Drug Administration ("FDA") for re-submission of a pre-Break Through Designation ("BTD"). If the pre-BTD submission is successful, this could lead to BTD approval. BTD approval right away after pre-BTD submission is ...more  
Comment by Legit62 on Oct 16, 2023 7:34am
Notice how careful they are with the wording
Comment by Oilminerdeluxe on Oct 16, 2023 7:37am
"65% of patients treated with Theralase's Anti-Cancer Therapy achieved a complete response." ???
Comment by Oilminerdeluxe on Oct 16, 2023 7:59am
Ah, it was not the durable response. Got mixed up there for a while. Liked this part at the end:  "Theralase® looks forward to commercializing this world-class technology for the benefit of all shareholders." Make it so, No 1.
Comment by enriquesuave on Oct 16, 2023 8:02am
Numbers are getting better and better especially at 180 and 270 days.  270 day Cr tend to maintain it till the end.  At 270 days Went up to 46% CR plus 12% IR= 58% TR and for optimized group went up to 50% CR and 13% IR= 63% TR.  Amazing This looks like a potential CR of 45-55% at 450 days IMHO after all these 62 patients reach 450 days. .
Comment by Longholder99 on Oct 16, 2023 8:15am
I smell a PR campaign designed to position Theralase well for JV negotiations which may already be in play.    While it's nice to see this info we have to assume the release served a purpose beyond 'good to know' ressons...just my opinion.  
Comment by Oilminerdeluxe on Oct 16, 2023 8:22am
Something must be behind this release. I didn't think we would see anything until the next Q report. Always happy too see updates. Perhaps JV negotiations as you say, or a boring but needed PP? We will see. That BTD would be soooo nice to have in the pocket. Perhaps the pre-application thing is very close now at least. 
Comment by StevenBirch on Oct 16, 2023 6:30pm
Yes an update so soon? The FDA requested a resubmission of the pre-BTD so you would think that if they clean up a couple of things that maybe THEY think BTD is in the offing. And Arkady says "This ACT technology...will be very attractive to patients & uro-oncologists (obvious) AND the insurance companies that insure these patients".  Every update exudes more confidence ...more  
Comment by 99942Apophis on Oct 16, 2023 7:23pm
Thank you StevenBirch that is more than likely one of the points outlined by the FDA what we saw and read in today's update. Exactly a clear patient update with current data numbers for the new Pre-BTD,  sometimes people just can't see what's right there in front of them. My bet today's update was part of the FDA’s request. Might I also say to those who are trying to inject ...more  
Comment by Yajne on Oct 16, 2023 7:37pm
99942, I love your optimism, particularly your prediction for SP at year-end. 
Comment by N0taP00p on Oct 16, 2023 11:54pm
@999: Unless people are a bit dense, it is easy to see that the "fear being injected" (that you allege) is from people who have been invested for long and seen the dilution and delay movie play on repeat.  We'll see if your prediction of $4 by this year plays out as well as January warrants being  exercised at 50 cents.  I'm sticking with the Nov/Dec dilution story ...more  
Comment by 99942Apophis on Oct 17, 2023 9:46am
Thanks NOtaPOOp, I'm analytical by nature and have to say no company will release this many NRs within a 3 week time span for a small financial raise,  it doesn't follow a typical business strategy. Weigh the evidence at hand (1) last Pre-BTD with suggestion of required data & format (2) ongoing conversation with FDA points to a more successful next 1 or 2nd Pre-BTD attempt with ...more  
Comment by StevenBirch on Oct 17, 2023 10:02am
Let's not be too hard on the negative Nellys, financing fear is one of the few arrows they have left in their quivers. If we don't allow them that then we are nothing more than
Comment by 99942Apophis on Oct 16, 2023 9:00am
Quite right Longholder99, this is a NR campaign that leads up to BTD and not too far after a partial & growing list of Pharmaceutical partners. In my opinion once Theralase enters commercialization revenue from this world network opportunity will result in billions of dollars.  We should also see after BTD &  Pharmaceutical partners are announced financial analysts climbing over ...more  
Comment by Donein25 on Oct 16, 2023 9:36am
Agreed all. Lets remeber too that a potential partner has to sell a deal to its shareholders; so it has to have Roger call Rudivar  "best-in class" on the record and Dr. Mandel describe it as "remarkable". This just sets up eventual deal PRs.
Comment by Tapps21 on Oct 16, 2023 9:39am
This is Theralase shouting from the rooftops " Our ACT  has life saving achievements so far that top some of the best treatments, come and make us an offer".  Keep up the great work RDW and yours (and our) dreams will come true 
Comment by BudFoxx2020 on Oct 25, 2023 4:26am
lolololololol.  Keep shouting off the top of the  roof.  While you at it just jumps.  Save people your nonsense.  The promoters.  Lolololol.  
Comment by N0taP00p on Oct 16, 2023 11:24am
Feels like an NR that did not tell us  substantially more than we already knew.  My previous gut feel and timing of calling PPs was close. So was my assertion that commercialization won't happen in  2023,  like many here had indicated.   To me, this feels like a gap filler NR because they are behind schedule in addressing pre clinical BTD questions. They need ...more  
Comment by Oilminerdeluxe on Oct 16, 2023 11:36am
N0taP00p, BTD in Q1 isn't that long to wait. It just feels like it :-)
Comment by consultant99 on Oct 16, 2023 12:22pm
I always welcome news particularly when it is unexpected and positive. That said I have been in this stock long enough to be a little cynical. My first reaction was this release is a setup for another PP; the company continues to be underfunded and is not very successful in meeting their target raises.  When I looked at the numbers last year I concluded the 450 day response rate was trending ...more  
Comment by Longholder99 on Oct 16, 2023 12:29pm
Another of many 'I hope I'm wrong but....' posts.  Interesting pattern when you go through the post history.  Usually when data points are upcoming or when new info points to things going well.   Ignore overdue but rectified.  
Comment by N0taP00p on Oct 16, 2023 1:08pm
@consultant99: Been wondering the same. I think it might be the hangover from Photofrin and it's side effects that may be hampering the acceptance of PDTs as a mainstream option.  Hopefully, the message about safety will get through eventually. Don't know about convertible debentures as an option. They don't have anything other than patents as an asset right now. Once those are ...more  
Comment by Eoganacht on Oct 16, 2023 1:42pm
Hopefully old school urologists and big pharma will listen to the experts - this ain't your grandpappy's oncological PDT! Ashish Kamat: Yeah. Speaking of systemic side effects, I remember the previous times of photosensitizers, where patients had to literally cover themselves from head to toe and go about. And you don't have to do that with this one. If you could just enlighten ...more  
Comment by jicoop on Oct 16, 2023 1:21pm
I'm still lurking here with my 10 years worth of accumulated shares. We are getting closer it appears. I was expecting CR rate of between 25 and 20% for 450 days , so I'm pleased to see the current numbers. As for your question about slow enrollment numbers, I have expressed my theory in the past, that most of the sites are US based, and they will give "other" treatments priority ...more  
Comment by CAinPlap on Oct 16, 2023 1:33pm
The pace of patient enrollment and treatment has been a sore spot for me for a long time. My jaded opinion is that we are competing for patients with Big Pharma backed trials and they have more resources to "influence" those in the position to suggest to the patients which trial to particiapte in. I also feel our lack of financial resources also plays a big part.
Comment by DeathXray33 on Oct 16, 2023 1:57pm
"I beleive there are powers that still are in not willing to see us succeed" Believe me; there are EVIL FORCES AROUND US... ie: No response in any patients at one specific site. Hmmm... Are you listening?
Comment by tdon1229 on Oct 16, 2023 8:23pm
consultant99, To answer one of your questions, FDA clinical trial sites are paid up front for their participation...no money, no new trial sites.
Comment by FGPstock on Oct 16, 2023 9:29pm
  not sure I believe in the powers to b holding the stock down. Todays news was great, only 300k+ shares traded, 60-70k US. As usual, we have a lack of buyers and exposure despite how good the release is. Markie/e search capital or whatever they name is has raised most of the money over the years for Tlt and have a "speculative buy" w a target of ,80c. Not sure y they are not ...more  
Comment by Infinity on Oct 17, 2023 7:42am
i like the optimism expressed on the board with projected stock prices shooting up before the end of this year.  I get it that we are close to getting BTD and possibly AA.  It looks from RDW's statement that we have 57 evaluable patients and I believe he mentioned that we need 100 evaluable patients in an earlier report.  Reading his latest statement I think the timelines are ...more  
Comment by Legit62 on Oct 17, 2023 7:50am
I believe the those timelines are the same, i believe we will get BTD and AA very soon which will change things drastically, JV possibly in the talks now, but waiting to get BTD before things heat up. Our results are too good to delay this treatment for the poor patients who drastically need it, one thing is for sure, Roger going to optimize his financial stake one way or the other
Comment by NgamiaSwede on Oct 17, 2023 8:39am
When news about BTD and AA comes, there will be alot of investors that will need to get a grip of what this is. The latest news was easy to read and understand. The news we seen before when there was an update was not easy to understand. I think that was what it was. A much easier way to value the big news that is coming. GLTA
Comment by FGPstock on Oct 17, 2023 9:13am
  Swede, we have all been waiting for that news for a LONG time. 25 cents is getting old  
Comment by gebremeskel on Oct 17, 2023 11:32am
You think you've been waiting a long time? NgamiaSwede has been posting here since 2014.
Comment by Oilminerdeluxe on Oct 17, 2023 11:38am
I used to have long, beautiful, thick, red, viking hair when I first got here. Now I have the same haircut as Roger, lol. It's been a while...
Comment by skys1 on Oct 17, 2023 12:06pm
I've got you all beat. I bought my first 10K shares of TLT when I was 63. I'm now 81. That equals 18 years.
Comment by gebremeskel on Oct 17, 2023 12:32pm
Holy Moly! That's a long wait skys1 Here's hoping Theralase makes you a millionaire before your 20 year anniversary.
Comment by Oilminerdeluxe on Oct 17, 2023 12:33pm
That is patience on a whole other level.
Comment by NgamiaSwede on Oct 17, 2023 12:11pm
Oil I have allways seen the shart of Theralase as a Giraffe, we are now at the tail and is going to the head. But I have never seen a Giraffe with a tail like this.... Yes for sure, grey hair for me to
Comment by Oilminerdeluxe on Oct 17, 2023 12:23pm
Let''s just hope the giraffe does not decide to eat grass for the rest of his life :-) Reach for apples instead! 
Comment by Impalaman on Oct 17, 2023 12:50pm
Swede--I'm also hanging on to that tail---15 years--and looking up and hopeing I doen't get SH_T on.
Comment by NgamiaSwede on Oct 17, 2023 3:42pm
Impalaman i was married for 22 years now I have a girlfriend, we are at 8 yesrs now they say you should not get married to your investment, but if Roger can do this his way and no shark eats him I will probably have Theralase for my longest girlfriend. I have told it before. I will sell my last shares at 32 CAD after a long and happy marridge GLTA
Comment by Oilminerdeluxe on Oct 17, 2023 4:03pm
If Roger gets us to $32, I will tattoo his face on my belly.
Comment by BlueFranky on Oct 17, 2023 4:16pm
" I will tattoo his face on my belly" ...Spitting coffee everywhere!! ;-)
Comment by Alamir1111 on Oct 17, 2023 4:39pm
32 $ is achievable. Only takes a reverse split 1000 to 1
Comment by Feedman2980 on Oct 17, 2023 4:47pm
Let's get to $1 and go from there. We have been 20-30 cents way too long. We have good news and SP stays dormant
Comment by Rumpl3StiltSkin on Oct 18, 2023 9:15am
I'm with ya. And I also spit up some coffee just now.
Comment by socksnblonds642 on Oct 17, 2023 11:38am
Hi Death, where did yo uget the site specific info? I wasn't aware we had that!
Comment by socksnblonds642 on Oct 16, 2023 8:15am
This is amazing. Would also be interesting to know about patients 5 and 6 after what, 5 years or so. One treatment. Wonder if the company can even access that info. 
Comment by Eoganacht on Oct 16, 2023 11:22am
enriquesuave wrote: "This looks like a potential CR of 45-55% at 450 days" That would be most excellent! Imagine if doctors were able to say to NMIBC patients: "So, BCG did not cure your bladder cancer and you need to know if removing your bladder is your best bet for surival? Before you have that done there is one other option - come into the office for a safe 2 hour out ...more  
Comment by skys1 on Oct 16, 2023 11:57am
A 45-50% CR is a 50/50 possibility. WOW! if I had cancer and was told with this treatment I had a 50/50 chance of the cancer disapearing I would jump at the opportunity.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250